Significant association of enhancer of zeste 2 (EZH2) genotypes with bladder cancer risk in Taiwan

被引:0
|
作者
Liao, Cheng-Hsi [1 ,2 ,3 ,4 ]
Chang, Wen-Shin [2 ,4 ]
Wu, Hsi-Chin [5 ]
Tsai, Chia-Wen [2 ,4 ]
Bau, Da-Tian [2 ,3 ,4 ]
机构
[1] Taichung Armed Forces Gen Hosp, Dept Surg, Taichung, Taiwan
[2] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan
[3] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan
[4] Terry Fox Canc Res Lab, Taichung, Taiwan
[5] China Med Univ Hosp, Taichung, Taiwan
关键词
genotype; Zeste 5(EZH2); polymorphism; renal cell carcinoma; Taiwan;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
MP-146
引用
收藏
页码:324 / 324
页数:1
相关论文
共 50 条
  • [1] Association of Enhancer of Zeste 2 (EZH2) Genotypes with Bladder Cancer Risk in Taiwan
    Chang, Wen-Shin
    Liao, Cheng-Hsi
    Tsai, Chia-Wen
    Hu, Pei-Shin
    Wu, Hsi-Chin
    Hsu, Shih-Wei
    Hsiao, Chieh-Lun
    Hsu, Chang-Hsien
    Hung, Yi-Wen
    Bau, Da-Tian
    [J]. ANTICANCER RESEARCH, 2016, 36 (09) : 4509 - 4514
  • [2] Enhancer of zeste homolog 2 (EZH2) expression in bladder cancer
    Warrick, Joshua I.
    Raman, Jay D.
    Kaag, Matthew
    Bruggeman, Trey
    Cates, Justin
    Clark, Peter
    DeGraff, David J.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (06) : 258.e1 - 258.e6
  • [3] Association of EZH2 Genotypes With Oral Cancer Risk
    Shih, Liang-Chun
    Tsai, Chia-Wen
    Lin, Tzu-Chieh
    Wang, Yun-Chi
    He, Jie-Long
    Hsu, Che-Lun
    Hsia, Te-Chun
    Tsai, Fuu-Jen
    Yang, Jai-Sing
    Hsu, Yuan-Man
    Bau, Da-Tian
    Chang, Wen-Shin
    [J]. IN VIVO, 2022, 36 (06): : 2669 - 2677
  • [4] Enhancer of zeste homolog 2 (EZH2) inhibitors
    Gulati, Nitya
    Beguelin, Wendy
    Giulino-Roth, Lisa
    [J]. LEUKEMIA & LYMPHOMA, 2018, 59 (07) : 1574 - 1585
  • [5] Value of Enhancer of Zeste Homolog 2 (EZH2) for Determining Prognosis in Colon Cancer
    Gholami, Nassrin
    Sanaat, Zohreh
    Dolatkhah, Roya
    Nikanfar, Alireza
    Esfahani, Ali
    Danandehmehr, Amin
    Akhrjou, Ashraf
    Farassati, Faris
    [J]. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2020, 14 (03)
  • [6] The enhancer of zeste homolog 2 (EZH2) expression level correlates with clinical grading of bladder carcinomas
    Muller, M
    Krause, H
    Weikert, S
    Miller, K
    [J]. JOURNAL OF UROLOGY, 2004, 171 (04): : 194 - 194
  • [7] Enhancer of Zeste Homolog 2 (EZH2) in Malignant Progression of Gallbladder Carcinoma
    Gayatri Behera
    Suvradeep Mitra
    Tushar S Mishra
    Suvendu Purkait
    [J]. Journal of Gastrointestinal Cancer, 2021, 52 : 1029 - 1034
  • [8] Epigenetic Control of Osteoblast Differentiation by Enhancer of Zeste Homolog 2 (EZH2)
    Amel Dudakovic
    Andre J. van Wijnen
    [J]. Current Molecular Biology Reports, 2017, 3 (2) : 94 - 106
  • [9] The effect of prognosis value of EZH2 (Enhancer Of Zeste Homologue) staining in hepatocellular cancer
    Kidi, M. M.
    Sahin, B.
    Bayram, E.
    Buyuksimsek, M.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S601 - S602
  • [10] Enhancer of Zeste Homolog 2 (EZH2) in Malignant Progression of Gallbladder Carcinoma
    Behera, Gayatri
    Mitra, Suvradeep
    Mishra, Tushar S.
    Purkait, Suvendu
    [J]. JOURNAL OF GASTROINTESTINAL CANCER, 2021, 52 (03) : 1029 - 1034